Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bank of America (NY:BAC)

51.80 +0.31 (+0.60%)
Official Closing Price Updated: 7:00 PM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bank of America

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Lennar Stock: Is Wall Street Bullish or Bearish?
Lennar has underperformed the broader market over the past year, and analysts are moderately pessimistic about the stock’s prospects. 
Via Barchart.com
Topics ETFs
News headline image
J.B. Hunt Says Freight Rates Are Rising as Capacity Tightens, Not Demand ↗
Executives from J.B. Hunt Transport Services (NASDAQ:JBHT) said freight-market conditions are tightening, but they attributed much of the shift to capacity leaving the market rather than a broad-based... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Should You Forget Ripple and Buy This Nuclear Stock Instead? ↗
Ripple is promising, but nuclear stocks could be a better bargain. 
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
Best Bank Stocks to Buy in 2026 ↗
With credit conditions potentially worsening in the second half of the year, look for a flight to safety. 
Via The Motley Fool
Topics Economy
News headline image
Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus ↗
Insmed (NASDAQ:INSM) Chair and CEO Will Lewis said the company remains confident in the launch trajectory of BRINSUPRI, despite investor concerns over discontinuation rates that followed the company’s... 
Via MarketBeat
News headline image
2 Nuclear Energy Stocks to Buy in May ↗
Nuclear energy could grow into a $10 trillion industry in the next 25 years. For investors who are bullish on nuclear, these two stocks are absolute buys. 
Via The Motley Fool
Topics Artificial Intelligence Supply Chain
News headline image
Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build ↗
Incyte (NASDAQ:INCY) President and CEO Bill Meury said the company’s post-Jakafi growth profile has become “much clearer” over the past year, pointing to continued growth in its commercial business,... 
Via MarketBeat
News headline image
IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data ↗
IDEAYA Biosciences (NASDAQ:IDYA) said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also... 
Via MarketBeat
News headline image
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears ↗
Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer... 
Via MarketBeat
Topics Economy
News headline image
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness ↗
Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while... 
Via MarketBeat
Topics Artificial Intelligence Supply Chain
News headline image
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead ↗
GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who... 
Via MarketBeat
News headline image
Citigroup's Quiet Turnaround: Is the Stock Finally Worth Buying? ↗
Shares of Citigroup have risen by more than 60% over the past year, trouncing the performance of many peers. 
Via The Motley Fool
News headline image
Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline ↗
Gilead Sciences (NASDAQ:GILD) Chief Commercial Officer and Head of Corporate Affairs Johanna Mercier said the company is leaning on its HIV business while continuing to build out oncology and... 
Via MarketBeat
News headline image
GE HealthCare Technologies Sticks to Growth Story After Inflation-Driven Guidance Cut ↗
GE HealthCare Technologies (NASDAQ:GEHC) executives said the company remains confident in its long-term growth prospects despite a disappointing first quarter that led to a reduction in full-year... 
Via MarketBeat
News headline image
Analyst Predicts Nvidia Stock Should Be 42% Higher ↗
Nvidia is well-positioned to continue shaping the future of artificial intelligence. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy ↗
4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage... 
Via MarketBeat
News headline image
Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference ↗
Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, highlighting early clinical activity for ERAS-0015 in lung, pancreatic and... 
Via MarketBeat
News headline image
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification ↗
Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and... 
Via MarketBeat
News headline image
Denali Therapeutics Says AVLAYAH Launch Ahead of Expectations After Hunter Syndrome Approval ↗
Denali Therapeutics (NASDAQ:DNLI) is seeing early commercial interest for its first approved drug, AVLAYAH, following its March 24 accelerated approval for Hunter syndrome, Chief Operating Officer and... 
Via MarketBeat
News headline image
CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms ↗
CRISPR Therapeutics (NASDAQ:CRSP) Chief Executive Officer Sam Kulkarni said the company is entering a “second phase” as it moves beyond the initial launch of CASGEVY and prepares for data from multiple... 
Via MarketBeat
Topics Intellectual Property
News headline image
Akamai Stock Is Surging on an Analyst Upgrade. It’s No Longer a Legacy Tech Company.
Akamai stock is soaring as Bank of America says the company is rapidly emerging as a major AI infrastructure player, boosting its price target to $175. 
Via Barchart.com
Topics Artificial Intelligence
News headline image
Why Bank of America Could Be the Best Value Among the Big Banks Right Now ↗
Bank of America is one of Warren Buffett's favorite stocks. 
Via The Motley Fool
News headline image
Here's What the Latest Inflation Data Could Mean for Crypto ↗
This bearish inflation report could rain on the parade when it's just getting restarted. 
Via The Motley Fool
Topics Economy
News headline image
Click n’ Close expands Whole Loan Trading division with engagement of Christy Soukhamneut and Launch Point Advisory Group
ADDISON, Texas, May 15, 2026 (SEND2PRESS NEWSWIRE) -- Click n' Close, a multi-state mortgage lender, announced strategic engagement of Christy Soukhamneut and Launch Point Advisory Group to support the... 
Via Send2Press
News headline image
CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears ↗
CG Oncology (NASDAQ:CGON) executives said the company remains on track to complete a rolling biologics license application for cretostimogene in BCG-unresponsive high-risk non-muscle invasive bladder... 
Via MarketBeat
Topics Initial Public Offering
News headline image
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records ↗
CeriBell (NASDAQ:CBLL) executives said the company’s first-quarter results reflected continued momentum in both new account additions and increased usage among existing hospital customers, while... 
Via MarketBeat
News headline image
1 Mega-Cap Stock to Own for Decades and 2 We Turn Down
Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less roo... 
Via StockStory
News headline image
Biogen Conference: Lupus, Kidney Programs Take Center Stage in Immunology Push ↗
Biogen (NASDAQ:BIIB) is continuing to position immunology as a larger part of its strategy, with late-stage lupus and kidney disease programs expected to shape the company’s next phase of growth, Adam... 
Via MarketBeat
News headline image
Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data ↗
Bicara Therapeutics (NASDAQ:BCAX) said its lead cancer drug candidate, ficerafusp alfa, remains on track for pivotal data in head and neck cancer in mid-2026, as the company outlined its development... 
Via MarketBeat
News headline image
Why Nvidia (NVDA) Stock Is Trading Up Today
What Happened? Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) jumped 3.7% in the afternoon session after a Reuters report indicated the US... 
Via StockStory
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.